Medication info

Suclear Liquid

Prescription medicationSolutionOral
Ingredient · strength
Anhydrous Sodium Sulfate›17.5g / 1 bottlePotassium Sulfate›3.13g / 1 bottleAnhydrous Magnesium Sulfate›1.6g / 1 bottle
Manufacturer / importer
Korea Pharmbio Co., Ltd.
Appearance
A colorless to pale yellow transparent liquid with an orange flavor, in a brown plastic container.
Packaging
2 bottles (177mL each) per box
Approval status
Active

MFDS item code 201405965 · Notified 2014.12.19 · Insurance code 659900920

Summary

Main use
Improves bowel preparation through bowel cleansing before colonoscopy
Who takes it
Adults
Adult dose
1. Preparation of the solution Pour the contents of 1 bottle of this drug (177 mL) into a mixing container and add water to the fill line on the container (approximately 473 mL). 2. Dosage and administration For adults, take the dose in divided doses as follows. 1) The day before the examination In the early evening on the day before the examination, drink all of the prepared solution. Over the course of 1 hour, fill the empty container with water to the fill line (approximately 473 mL) and drink it twice. 2) The day of the examination On the morning of the examination, 10~12 hours after taking the medication the previous evening, prepare a second solution and drink all of it. Over the course of 1 hour, fill the empty container with water to the fill line (approximately 473 mL) and drink it twice. Complete taking this drug and drinking additional water at least 2 hours before the examination or by the time instructed by your doctor. On the day before the examination, eat a light breakfast or consume only clear liquids. On the day of the examination, consume only clear liquids until the examination.

Ingredients

Manufacturer
Korea Pharmbio Co., Ltd.

Efficacy & effects

Improves bowel preparation through bowel cleansing before colonoscopy

View approved original text

This medication is used to thoroughly cleanse the bowel prior to colon X-ray or endoscopic examinations. It should not be used for the purpose of treating constipation. It helps remove waste products in the intestine to facilitate the smooth progression of the examination.

How to take

Adult dose

1. Preparation of the solution Pour the contents of 1 bottle of this drug (177 mL) into a mixing container and add water to the fill line on the container (approximately 473 mL). 2. Dosage and administration For adults, take the dose in divided doses as follows. 1) The day before the examination In the early evening on the day before the examination, drink all of the prepared solution. Over the course of 1 hour, fill the empty container with water to the fill line (approximately 473 mL) and drink it twice. 2) The day of the examination On the morning of the examination, 10~12 hours after taking the medication the previous evening, prepare a second solution and drink all of it. Over the course of 1 hour, fill the empty container with water to the fill line (approximately 473 mL) and drink it twice. Complete taking this drug and drinking additional water at least 2 hours before the examination or by the time instructed by your doctor. On the day before the examination, eat a light breakfast or consume only clear liquids. On the day of the examination, consume only clear liquids until the examination.

Precautions

This medication should not be used in patients who are hypersensitive to this medication or its components. Administration should also be avoided in patients with suspected or confirmed gastrointestinal obstruction or perforation, as well as those with gastric stasis or intestinal obstruction. It is safest not to use this medication in patients with toxic colitis or toxic megacolon, and those with severe renal dysfunction. Patients with severe dehydration, ascites, or congestive heart failure should also avoid this medication. Caution is advised in patients with severe electrolyte and serum chemistry abnormalities, those with a history of seizures or at high risk for seizures, and those at risk for arrhythmias. Additionally, patients on medications that may affect renal function, those with bowel mucosal ulcers or ischemic colitis, and patients with severe active ulcerative colitis also require careful attention. Special caution is needed for patients with impaired vomiting reflex or those prone to aspiration and reflux. This medication may induce diarrhea after administration, so adequate fluid intake is necessary, and it is advisable to monitor for electrolyte and renal function if vomiting or dehydration symptoms arise. Electrolyte imbalances can lead to serious arrhythmias, seizures, or worsening renal function, necessitating careful management of fluid and electrolyte status. Even in patients without a history of seizures, seizures or loss of consciousness can occur rarely, thus extra caution should be exercised in patients at high risk for seizures. This medication can temporarily elevate uric acid levels, potentially triggering acute attacks in gout patients, necessitating caution. Patients with heart disease or a high risk of arrhythmias should consider undergoing an electrocardiogram prior to administration. Careful administration of this medication is warranted in patients with impaired renal function or those on medications affecting the kidneys, along with thorough monitoring of the patient's status and ensuring adequate fluid intake. This medication may cause ulcers in the bowel mucosa; therefore, concomitant use with irritant laxatives should be avoided, and caution is required in interpreting test results in patients with inflammatory bowel disease. This medication must be thoroughly diluted in water before ingestion; failure to do so may increase the risk of nausea, vomiting, dehydration, and electrolyte imbalances. Drugs taken within 1 hour prior to taking this medication may be washed away by it, potentially interfering with absorption, thus caution is warranted. It should only be administered to pregnant women when the diagnostic benefit outweighs the risks, and it is unknown whether this medication is excreted in breast milk, so it should be used cautiously in breastfeeding women. Safety and efficacy in children have not been established, so caution is necessary in their use. Elderly patients are at higher risk for diminished liver, kidney, and heart function as well as susceptibility to electrolyte abnormalities, necessitating careful administration.

Side effects

  • General discomfort
  • abdominal distension
  • abdominal pain
  • nausea
  • vomiting
  • headache
  • decreased blood bicarbonate
  • increased blood calcium
  • increased blood uric acid
  • increased anion gap
Show 7 more
  • increased total bilirubin
  • increased blood urea nitrogen
  • increased blood chloride ions
  • increased blood creatinine
  • decreased and increased blood osmolality
  • increased blood potassium
  • decreased blood sodium

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. Avoid excessively hot or cold environments, and it is best to store it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

A colorless to pale yellow transparent liquid with an orange flavor, in a brown plastic container.

Package unit

2 bottles (177mL each) per box

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.